Literature DB >> 35873609

A Molecular Insight of the Role of PIN-1 Promoter Polymorphism (- 667C > T; rs2233679) in Chronic Kidney Disease Patients with Secondary Hyperparathyroidism.

Digishaben D Patel1, Deepak Parchwani1, Uday Vachhani2, Tanishk Parchwani3, Pratik Raghavani2, Ajay Rajput2, Sagar Dholariya1, Ragini Singh1.   

Abstract

Murine studies stipulate Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 (PIN-1) as a key mediator of PTH mRNA stability and is acknowledged by genome-wide-association-studies as secondary hyperparathyroidism defining trait in chronic kidney disease. Therefore, we hypothesize that molecular variants of the PIN-1 gene might affect the incidence and predisposition to secondary hyperparathyroidism in chronic renal insufficiency. A total of 281 adult participants, including 124 chronic kidney disease patients with secondary hyperparathyroidism and 157 healthy controls, were genotyped using polymerase chain reaction-restriction fragment length polymorphism method to unravel the effects of genetic risk loci (PIN-1 gene; - 667C > T; rs2233679) on the susceptibility to secondary hyperparathyroidism in chronic kidney disease. Suitable descriptive statistics was used for different variables. The genotype (x2: 8.03, 2 d. f. p = 0.0181) and allele distribution (x2: 7.27, 2 d. f. p: 0.007) of the - 667C > T variant differed significantly in cases and controls, with no deviation from Hardy-Weinberg equilibrium in either affected or control group. The observed frequencies of T allele of PIN-1 - 667 C > T SNP was significantly high in CKD-SHPT group compared to control group (52.41% vs. 41.71%; p: 0.0118). TT variant of PIN-1 - 667C > T SNP was associated with increased risk for occurrence of CKD-SHPT in univariate analysis (OR: 4.6, p: 0.0032, 95% CI: 1.66-12.76). Further in multivariate analysis, both TT (OR: 3.84, p: 0.002, 95% CI: 0.79-9.26) and CT + TT (OR: 2.51, p: 0.031, 95% CI: 0.64-8.68) variants were independently associated with increased risk for CKD-SHPT, emphasizing the deleterious effect of minor T allele. Serum PTH, phosphorus levels were significantly high in CT and TT genotypes compared to CC genotype of PIN-1 - 667C > T SNP (p = 0.001). PIN-1 promoter functional SNP (- 667C > T; rs2233679) appeared to be an important genetic determinant in etiopathogenesis of CKD-SHPT and genetic variants of this SNP influences the risk stratification and might serve as a predictive marker. Thus, rs2233679 can be useful for outcome predictions during diagnostic processes. © Association of Clinical Biochemists of India 2021.

Entities:  

Keywords:  Chronic kidney disease; PCR–RFLP; PIN-1; Secondary hyperparathyroidism

Year:  2021        PMID: 35873609      PMCID: PMC9300778          DOI: 10.1007/s12291-021-00997-8

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  28 in total

1.  The Pin1 gene polymorphism and the susceptibility of oral squamous cell carcinoma in East China.

Authors:  Jie Yao; Jian-Ming Wang; Zi-Lu Wang; Yu-Nong Wu
Journal:  Cancer Biomark       Date:  2014       Impact factor: 4.388

2.  AU binding proteins recruit the exosome to degrade ARE-containing mRNAs.

Authors:  C Y Chen; R Gherzi; S E Ong; E L Chan; R Raijmakers; G J Pruijn; G Stoecklin; C Moroni; M Mann; M Karin
Journal:  Cell       Date:  2001-11-16       Impact factor: 41.582

3.  A rapid method for the purification of DNA from blood.

Authors:  M Jeanpierre
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

4.  A conserved cis-acting element in the parathyroid hormone 3'-untranslated region is sufficient for regulation of RNA stability by calcium and phosphate.

Authors:  R Kilav; J Silver; T Naveh-Many
Journal:  J Biol Chem       Date:  2000-12-15       Impact factor: 5.157

Review 5.  Vitamin D for health and in chronic kidney disease.

Authors:  Michael F Holick
Journal:  Semin Dial       Date:  2005 Jul-Aug       Impact factor: 3.455

Review 6.  Post-transcriptional mechanisms regulating parathyroid hormone gene expression in secondary hyperparathyroidism.

Authors:  Rachel Kilav-Levin; Alia Hassan; Morris Nechama; Vitali Shilo; Justin Silver; Iddo Z Ben-Dov; Tally Naveh-Many
Journal:  FEBS J       Date:  2020-04-09       Impact factor: 5.542

7.  KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD).

Authors: 
Journal:  Kidney Int Suppl       Date:  2009-08       Impact factor: 10.545

8.  The parathyroid hormone mRNA 3'-untranslated region AU-rich element is an unstructured functional element.

Authors:  Rachel Kilav; Osnat Bell; Shu-Yun Le; Justin Silver; Tally Naveh-Many
Journal:  J Biol Chem       Date:  2003-10-29       Impact factor: 5.157

9.  Pin1 and secondary hyperparathyroidism of chronic kidney disease: gene polymorphisms and protein levels.

Authors:  Yu Zhao; Li-Li Zhang; Fa-Xian Ding; Ping Cao; Yuan-Yuan Qi; Jing Wang
Journal:  Ren Fail       Date:  2016-11-23       Impact factor: 2.606

Review 10.  Pinning Down the Transcription: A Role for Peptidyl-Prolyl cis-trans Isomerase Pin1 in Gene Expression.

Authors:  Xiangming Hu; Lin-Feng Chen
Journal:  Front Cell Dev Biol       Date:  2020-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.